Science Explorer Back to mapMap
Discussion
Researcher · National Taiwan University Hospital · Taiwan

Ann‐Lii Cheng

Ann‐Lii Cheng publishes mostly in Oncology, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-9152-6512 OpenAlex
World rank
#217,363
of 7,710,434 ranked researchers
Rank in Taiwan
#644
of 57,035
Works
1,253
Citations
77k
Citations per work
61.4
h-index
99
i10-index 540Top 0.4% in Oncology
Ann‐Lii Cheng

What does Ann‐Lii Cheng research?

Ann‐Lii Cheng's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (17%).

Health Sciences: 694 works · 55.4% of their workMedicine: 694 works · 55.4% of their workOncology: 281 works · 22.4% of their workHepatology: 190 works · 15.2% of their workPulmonary and Respiratory Medicine: 134 works · 10.7% of their workPathology and Forensic Medicine: 89 works · 7.1% of their workEverything else: 350 works · 27.9% of their workLife Sciences: 209 works · 16.7% of their workBiochemistry, Genetics and Molecular Biology: 209 works · 16.7% of their workMolecular Biology: 130 works · 10.4% of their workCancer Research: 79 works · 6.3% of their workTHEIR WORKAnn‐Lii Cheng1,253works
Life Sciences17%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine69455.4%
  2. Everything else35027.9%
    1. Biochemistry, Genetics and Molecular Biology20916.7%
  1. 1Oncology22% of their works
  2. 2Hepatology15% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Molecular Biology10% of their works
  5. 5Pathology and Forensic Medicine7% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Ann‐Lii Cheng's research?

The keywords of their largest research topics: Clinical Practice Guidelines, Hepatocellular Carcinoma, Liver Cancer, Chemotherapy, Tumor Microenvironment, Cetuximab, KRAS Mutations and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Clinical Practice Guidelines4582 topics
  2. Hepatocellular Carcinoma3891 topic
  3. Liver Cancer3891 topic
  4. Chemotherapy3153 topics
  5. Tumor Microenvironment2062 topics
  6. Cetuximab1661 topic
  7. KRAS Mutations1661 topic
  8. Immune Checkpoint Blockade1261 topic
  9. PD-1 and PD-L11261 topic
  10. EGFR Mutations1121 topic
  11. Targeted Therapy1121 topic
  12. Pim Oncogenes951 topic
  13. Tumorigenesis951 topic
  14. Classification911 topic
  15. Lymphoma911 topic
  16. Pancreatic Cancer801 topic
  17. Surgical Complications801 topic
  18. Endoscopic Resection691 topic
  19. Gastric Cancer691 topic

Where does Ann‐Lii Cheng work?

Ann‐Lii Cheng's main affiliation in the publication record is National Taiwan University Hospital, Taiwan.

How many publications and citations does Ann‐Lii Cheng have?

OpenAlex counts 1,253 works and 76,932 citations for Ann‐Lii Cheng, an h-index of 99, ranking #217,363 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ann‐Lii Cheng. Posts are plain text and can be reported.